IRIS
MANTOVANI, LORENZO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.559
NA - Nord America 2.074
EU - Europa 1.703
SA - Sud America 367
AF - Africa 77
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.789
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.003
SG - Singapore 1.308
RU - Federazione Russa 753
VN - Vietnam 430
CN - Cina 372
BR - Brasile 314
HK - Hong Kong 231
IT - Italia 218
UA - Ucraina 139
DE - Germania 117
FR - Francia 113
FI - Finlandia 106
IE - Irlanda 63
NL - Olanda 59
GB - Regno Unito 55
CA - Canada 41
IN - India 38
JP - Giappone 38
CI - Costa d'Avorio 25
ZA - Sudafrica 23
BD - Bangladesh 21
SE - Svezia 18
AR - Argentina 17
KR - Corea 15
PH - Filippine 15
PL - Polonia 15
MX - Messico 14
EC - Ecuador 12
ID - Indonesia 12
IQ - Iraq 12
AT - Austria 10
CO - Colombia 8
MA - Marocco 8
TR - Turchia 8
PK - Pakistan 7
TH - Thailandia 7
CH - Svizzera 6
JO - Giordania 6
UZ - Uzbekistan 6
ES - Italia 5
VE - Venezuela 5
BE - Belgio 4
BG - Bulgaria 4
EG - Egitto 4
IL - Israele 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
CL - Cile 3
ET - Etiopia 3
KZ - Kazakistan 3
MY - Malesia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
NG - Nigeria 2
SV - El Salvador 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
MZ - Mozambico 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
Totale 6.784
Salva come PNG Salva come JPEG
Città #
Singapore 619
San Jose 339
Hong Kong 222
Moscow 173
Ashburn 147
Santa Clara 145
Ho Chi Minh City 134
Jacksonville 126
Hanoi 103
Chandler 86
Lauterbourg 83
Princeton 80
Napoli 79
Beijing 69
Boston 63
The Dalles 62
Nanjing 58
Los Angeles 56
Amsterdam 53
Millbury 45
Buffalo 39
São Paulo 32
Tokyo 31
Rome 29
Wilmington 29
Frankfurt am Main 27
Redondo Beach 26
Des Moines 23
New York 23
Council Bluffs 21
Orem 20
Hefei 19
Da Nang 17
Dallas 17
Haiphong 17
Jiaxing 17
Turku 17
Munich 16
Hebei 15
Chicago 14
Nanchang 14
Naples 14
Rio de Janeiro 13
Atlanta 12
Nuremberg 12
Brooklyn 11
London 11
Toronto 11
Warsaw 11
Falls Church 10
Mexico City 10
Norwalk 10
Shenyang 10
Belo Horizonte 8
Johannesburg 8
San Francisco 8
Biên Hòa 7
Changsha 7
Dublin 7
Houston 7
Milan 7
Cape Town 6
Curitiba 6
Denver 6
Helsinki 6
Lawrence 6
Miami 6
Phoenix 6
Seattle 6
Tashkent 6
Amman 5
Düsseldorf 5
Indiana 5
Manchester 5
Montreal 5
Porto Alegre 5
Pune 5
Rohtak 5
Thái Bình 5
Ankara 4
Baghdad 4
Brasília 4
Campinas 4
Can Tho 4
Chennai 4
Guayaquil 4
Krefeld 4
Ludhiana 4
Memphis 4
New Delhi 4
Paris 4
Poplar 4
Pyeongtaek-si 4
Quezon City 4
Seoul 4
Thái Nguyên 4
Tianjin 4
Vienna 4
Ann Arbor 3
Basel 3
Totale 3.580
Salva come PNG Salva come JPEG
Nome #
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019 164
Valutazione economica dello studio AVERT 153
Is preventive medical care worth the cost? 153
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 149
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 122
Adherence to antihypertensive medications and cardiovascular morbidity among newly-diagnosed hypertensive patients 117
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 113
Malattia di Alzheimer in Italia: impatto sociale, sanitario ed economico. Farmacoeconomia 112
Efficiency measures of emergency departments: an Italian systematic literature review 111
Do different physicians' panels reach similar conclusions? A case study on practice guidelines for limited surgery in breast cancer 108
Comparative analysis of the pivotal studies of extended half-life recombinant FVIII products for treatment of haemophilia A 106
Cost Minimization Analysis of Radiofrequency Compared to Laser Thermal Ablation in Patients with Hepatocellular Carcinoma 104
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 103
A proposal for Italian Guidelines in pharmacoeconomics 101
The value-based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia 99
Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact. 97
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 95
Valutazione farmacoeconomica dell’uso di tramadolo vs ketorolac nella gestione del dolore postoperatorio 94
Can Europe afford not to implement evidence-based medicine in heart failure? 93
Guidelines for economic evaluations in Italy: recommendations from the italian group of pharmacoeconomic studies 93
Caring for patients with Alzheimer’s disease in Italy 89
Good economic practices per gli studi di farmacoeconomia 85
I farmaci generici: aspetti chiave e situazione internazionale 85
An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom 85
Valutazione economica dello studio CARDS, aggiornamenti. 83
Farmacoeconomia 82
Quadro Teorico di Riferimento 81
Assistenza Territoriale 79
The cost of caring for patients with Psoriasis in Italy: results from the AISP Study 78
Francia 77
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment. 77
Captopril in the management of patients after acute myocardial infarction. A cost-effectiveness analysis in Italy 76
Cost-Benefit Analysis of Amtolmetin-Guacil 76
Burden of acute myocardial infarction 76
Pharmaco-economic aspects of recombinant FSH in women undergoing in-vitro fertilisation in Italy 75
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group 75
Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective 75
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study. 75
Germania 74
Costi e disabilità nei pazienti anziani oncologici 73
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. 72
Evaluation of scientific research concerning health in the less favored regions of the European Union: health care in three southern Member States (Spain, Greece and Italy) 71
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors 70
Cost Analysis of Capecitabine vs 5-Fluorouracil-Based Treatment for Metastatic Colorectal Cancer Patients 70
Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study 70
L-Carnitine use in hemodialiyed patients 68
Quality of life assessment in clinical practice in haemophilia treatment 68
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment 68
Haemophilia prophylaxis: how can we justify the costs? 68
Haemophilia Care in Europe: the ESCHQoL study 68
Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients 66
The importance of baseline viral load when assessing relative efficacy in treatment-na?ve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis. 66
Trattamento con etanercept dei soggetti con artrite reumatoide in Italia: considerazioni economiche 65
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. 65
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). 65
Caring for patients with Alzheimer's disease in Italy 64
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 64
Italian population-based values of EQ-5D health states. 63
The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study 62
KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting. 62
Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. 62
Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy 61
Setting dialysis start at 6.0 ml/min/1.73 m(2) eGFR-a study on safety, quality of life and economic impact 61
The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature 60
New pharmacoeconomic option in uremic anemia management 60
Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis. 60
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: An extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 60
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors 59
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 58
Is preventive medical care worth the cost? 58
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study. 58
Guidelines for economic evaluations in Italy: Recommendations from the Italian Group of Pharmacoeconomic Studies 57
The social burden and quality of life of patients with haemophilia in Italy. 56
Oral antiviral therapies are cost-effective vs. no treatment but indirect comparisons should be avoided 55
Healthcare costs associated with hepatocellular carcinoma and the value of care. 55
L-carnitine use in hemodialyzed patients 54
Pharmaco-economic aspects of in-vitro fertilization in Italy 54
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group 53
Cost-effectiveness of different diagnostic strategies to assess gastro-oesophageal reflux disease in patients with unexplained chronic persistent cough in Italy 53
The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients. 53
Uncovered needs in the management of inherited bleeding disorders in Italy. 53
Use of health-related quality-of-life measurements to estimate individuals' health on screening. 53
Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. 52
The perspective of a pharmacoeconomic study: Targeting for audiences 51
Major complications have an impact on total annual medical cost of diabetes - Results of a database analysis 51
The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. 51
Present and future challenges in the treatment of haemophilia: the patient's perspective. 49
Management of treatment-na?ve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options. 48
Clinical epidemiology of hand eczema in patients accessing dermatological reference centers: results from a Mediterranean Country. 46
Cost-Effectiveness Analysis of New Drugs for Chronic Hepatitis C: The Importance of Updating Utility Values. 46
Totale 6.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022299 1 0 6 0 0 16 0 14 55 34 21 152
2022/2023361 88 22 22 5 12 22 0 66 48 50 24 2
2023/2024284 11 45 29 13 14 9 14 39 4 4 79 23
2024/20251.966 109 167 10 20 20 142 241 69 166 193 660 169
2025/20263.169 346 260 298 296 505 122 348 207 433 203 61 90
2026/202778 78 0 0 0 0 0 0 0 0 0 0 0
Totale 6.845